Literature DB >> 12636090

Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases.

J Soga1.   

Abstract

This study was undertaken to evaluate the statistical results of a large collected series of primary hepatic endocrinomas including carcinoids from extensive clinicopathologic aspect, and to provide the information to investigators engaged in this particular field of research. Primary hepatic endocrinomas variously termed as endocrine cell carcinoma (ECC), neuroendocrine carcinoma (NEC), carcinoid, and other carcinomas with endocrine components (CECs), have been rarely reported in literature. A total of 126 reported cases were registered in the Niigata Registry for gut-pancreatic endocrinomas. They consisted of a carcinoid group with typical carcinoids (n=82) and atypical carcinoids (n=19) and another group with other variant endocrinomas, briefly expressed as the variant group (n=25) in this study. The number of females was larger than that of males in the carcinoid group (M/F=0.58) and reversely males were predominant in the variant group (M/F=1.78). The average age was considerably older in the carcinoid group as compared to that in the variant group (53.9 years vs 48.3 years). The carcinoid group (either typical, atypical or both) showed a significant lower value than the variant group in metastasis rates in the large (over 50 mm) tumor series (43.3% vs 75.0%: P<0.05), and higher than the latter in serotonin positivity demonstrated by immunohistochemistry (37.0% vs 11.1%). While no significant difference was present between the two groups, cases with large tumors over 50 mm were found at a high rate (P<0.01) in approximately three fourths of each group, i.e. 76 out of a total of 100 cases recorded, and the liver was more often involved by metastasis than lymph nodes in the carcinoid group (32.7% vs 19.8%: P<0.05) though no significant difference was noted between these two sites in the variant group. The five-year survival rates calculated by the Kaplan-Meier method showed better results in the carcinoid group than in the variant group but with no statistically significant difference (92.4% vs 68.1%). A close similarity found in many aspects of the two groups suggested endocrinomas in the present study apparently belong to one family of CECs or briefly "carcinoid family". Regarding the more detailed statistical analyses, further accumulation of well-documented cases is needed.

Entities:  

Mesh:

Year:  2002        PMID: 12636090

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  9 in total

1.  Primary hepatic carcinoid tumours.

Authors:  M Nikfarjam; V Muralidharan; C Christophi
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

2.  Giant atypical carcinoid of the liver with vascular metastases and local sinusoidal invasion: a case report.

Authors:  Daniel Lingamfelter; Laura Hoffman; Amit Verma; William Depond; Kamani Lankachandra
Journal:  J Med Case Rep       Date:  2007-07-12

Review 3.  Primary Hepatic Neuroendocrine Tumor: What Do We Know Now?

Authors:  Benjamin Quartey
Journal:  World J Oncol       Date:  2011-10-28

4.  Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.

Authors:  Meng-Jun Qiu; Yao-Bing Chen; Ning-Rui Bi; Sheng-Li Yang; Xiao-Xiao He; Zhi-Fan Xiong
Journal:  Dis Markers       Date:  2018-10-17       Impact factor: 3.434

5.  ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation.

Authors:  Sk Kayum Alam; Li Wang; Yanan Ren; Christina E Hernandez; Farhad Kosari; Anja C Roden; Rendong Yang; Luke H Hoeppner
Journal:  Br J Cancer       Date:  2020-06-05       Impact factor: 7.640

6.  Hepatectomy and pneumectomy combined with targeted therapy for primary hepatic neuroendocrine carcinoma: Case report and review of the literature.

Authors:  Keyu Huang; Zhujing Lan; Weitao Chen; Jianyong Zhang; Jilong Wang; Hai Zhu; Banghao Xu; Ling Zhang; Tingting Lu; Ya Guo; Zhang Wen
Journal:  Front Surg       Date:  2022-07-15

7.  Primary liver carcinoid tumour with a Zollinger Ellison syndrome - an unusual diagnosis: a case report.

Authors:  Gabriela Rascarachi; Mónica Sierra; Mercedes Hernando; Rubén Diez; Laura Arias; Francisco Jorquera; Santiago Vivas; José Luis Olcoz
Journal:  Cases J       Date:  2009-08-07

8.  Relatively Long Survival in Hepatocellular Carcinoma Presenting With Carcinoid Syndrome.

Authors:  Sylvester Chuks Nwokediuko; Ijoma Uchenna; Ofoegbu Esther; Okafor Okechukwu; Onuh Augustine; Ajuyah Charity
Journal:  Gastroenterology Res       Date:  2010-01-20

9.  Primary hepatic neuroendocrine neoplasm: Long-time surgical outcome and prognosis.

Authors:  Changying Shi; Qian Zhao; Binghua Dai; Feng Xie; Jiamei Yang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.